Heart graft preservation technics and limits: an update and perspectives
Frontiers in Cardiovascular Medicine · 06.11.2023 · 10
DOI: 10.3389/fcvm.2023.1248606 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 06.11.2023. Verfasst von Aurore Ughetto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Phymedexp INSERM, CNRS, University of Montpellier, CHRU Montpellier, Montpellier, France. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Heart transplantation, the gold standard treatment for end-stage heart failure, is limited by heart graft shortage, justifying expansion of the donor pool. Currently, static cold storage (SCS) of hearts from donations after brainstem death remains the standard practice, but it is usually limited to 240 min. Prolonged cold ischemia and ischemia-reperfusion injury (IRI) have been recognized as major causes of post-transplant graft failure. Continuous ex situ perfusion is a new approach for donor organ management to expand the donor pool and/or increase the utilization rate. Continuous ex situ machine perfusion (MP) can satisfy the metabolic needs of the myocardium, minimizing irreversible ischemic cell damage and cell death. Several hypothermic or normothermic MP methods have been developed and studied, particularly in the preclinical setting, but whether MP is superior to SCS remains controversial. Other approaches seem to be interesting for extending the pool of heart graft donors, such as blocking the paths of apoptosis and necrosis, extracellular vesicle therapy, or donor heart-specific gene therapy. In this systematic review, we summarize the mechanisms involved in IRI during heart transplantation and existing targeting therapies. We also critically evaluate all available data on continuous ex situ perfusion devices for adult donor hearts, highlighting its therapeutic potential and current limitations and shortcomings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Phymedexp INSERM, CNRS, University of Montpellier, CHRU Montpellier, Montpellier, France.
- Department of Anesthesiology and Critical Care Medicine, Arnaud de Villeneuve Hospital, CHU Montpellier, University of Montpellier, Montpellier, France.
- Cardiology Department, CHU de Montpellier, University of Montpellier, Montpellier, France.
- Cardio-thoracic and Vascular Surgery Department, CHU de Montpellier, University of Montpellier, Montpellier, France.
- Cardiac and Vascular Surgery, Marie Lanelongue Hospital, Paris Saclay University, Le Plessis Robinson, France.
- Intensive Cardiac Care Unit, Cardiology Department, Rangueil University Hospital, Toulouse, France.
Zitieren
APA
Ughetto, A., Roubille, F., Molina, A., Battistella, P., Gaudard, P., Demaria, R., Guihaire, J., Lacampagne, A., & Delmas, C. (2023). Heart graft preservation technics and limits: an update and perspectives. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1248606
Vancouver
Ughetto A, Roubille F, Molina A, Battistella P, Gaudard P, Demaria R, et al. Heart graft preservation technics and limits: an update and perspectives. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1248606
BibTeX
@article{Ughetto2023,
author = {Ughetto, Aurore and Roubille, François and Molina, Adrien and Battistella, Pascal and Gaudard, Philippe and Demaria, Roland and Guihaire, Julien and Lacampagne, Alain and Delmas, Clément},
title = {Heart graft preservation technics and limits: an update and perspectives},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1248606}
}
EUVIMED